Prevention of human papillomavirus (HPV)

In the case of prolonged HPV activity in the thickness of the skin or mucous membranes, as well as in the presence of certain types of high-risk cancer viruses, precancerous and cancerous changes may form - the so-called dysplasia of varying severity, or carcinomas. HPV most often provokes the development of cervical cancer, cancer of the neck of the bladder, rectum, penis, oropharynx.

The main directions in the prevention of HPV-related malignancies are timely diagnosis of the virus, determination of the cancer risk group (determination of the type of virus and the degree of cancer risk), proper and complete treatment and prevention of relapses and fresh infections.

In order to prevent high-risk HPV infection, according to the recommendations of the American Federal Committee for Practical Vaccination (ACIP), an antiviral vaccine is used. The vaccine is highly effective in preventing infection with HPV types 6, 11, 16, 18, which are high-risk viruses. According to the recommendations of the CDC (Center for Disease Control, USA), this vaccine is recommended for vaccination of girls and boys aged 11 to 26 years who are not sexually active, or adults after examination, in the absence of virus transmission or HPV incidence. The American Association for the Control of Public Health (ASHA) recommends the use of this vaccine for older men in order to accelerate the elimination of the virus from the body, reduce the frequency of renewal of genital warts and to reduce the risk of malignant changes.

The EMC Clinic of Gynecology and Oncogynecology successfully uses vaccine prophylaxis to prevent infection with high-risk HPV (6,11,16,18), using the Gardasil vaccine(Gardasil) manufactured by Merck&Co., Germany. We are pleased to offer you a new method of treating papillomavirus infection, which consists in administering a specific vaccine according to an international protocol. EMC dermatovenerologists vaccinate men and women who are already carriers of HPV. After vaccination, the immune system produces antibodies that help eliminate the virus. Studies conducted by our foreign colleagues confirm the high effectiveness of this type of vaccination, which promotes faster elimination of the virus from the body and significantly reduces the risk of recurrence of clinical manifestations of papillomavirus infection. This technique makes it possible to significantly enhance the effects of antiviral therapy.

Be healthy.